|
Summaries of Product Characteristics (SPC) for Human medicinal products
The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
Summaries of Product Characteristics 1 - 30 of 188 |
|
|
Package leaflet | Status for supply | Name of the medicinal product |
|
|
European Medicines Agency's website: Iasibon - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Ibandronat Stada 150 mg tabletti, kalvopäällysteinen SPC 2022-09-01
|
PL
|
Resepti
|
Ibandronate ratiopharm 150 mg tabletti, kalvopäällysteinen SPC 2022-09-23
|
PL
|
Resepti
|
Ibandronate ratiopharm 50 mg tabletti, kalvopäällysteinen SPC 2021-02-10
|
|
|
European Medicines Agency's website: Ibandronic acid Accord - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Ibandronic Acid Sandoz - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Ibandronic Acid Teva - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Ibrance - EMA: EPAR PI
Finnish Swedish
|
|
|
European Medicines Agency's website: Ibrance - EMA: EPAR PI
Finnish Swedish
|
PL
|
Itsehoito
|
Ibumax 200 mg, 400 mg tabletti, kalvopäällysteinen SPC 2023-12-19 OTC
|
PL
|
Resepti
|
Ibumax 200 mg, 400 mg, 600 mg, 800 mg tabletti, kalvopäällysteinen SPC 2023-12-19
|
PL
|
Resepti
|
Ibumax 200 mg, 400 mg, 600 mg, 800 mg tabletti, kalvopäällysteinen SPC 2023-12-19
|
PL
|
Resepti/itsehoito
|
Ibumax Lysin 400 mg tabletti, kalvopäällysteinen SPC 2023-12-19
|
PL
|
Itsehoito
|
Ibumax-C 400 mg-300mg tabletti, kalvopäällysteinen SPC 2023-12-19
|
PL
|
Resepti
|
Ibumetin 600 mg tabletti, kalvopäällysteinen SPC 2024-05-10
|
PL
|
Resepti
|
Ibuprofen Accord 400 mg tabletti, kalvopäällysteinen SPC 2024-03-13
|
PL
|
Resepti
|
Ibuprofen Accord 600 mg tabletti, kalvopäällysteinen SPC 2024-03-13
|
PL
|
Resepti
|
Ibuprofen B. Braun 200 mg infuusioneste, liuos SPC 2024-05-07
|
PL
|
Resepti
|
Ibuprofen B. Braun 400 mg infuusioneste, liuos SPC 2024-05-07
|
PL
|
Resepti
|
Ibuprofen B. Braun 600 mg infuusioneste, liuos SPC 2024-05-07
|
PL
|
Resepti/itsehoito
|
Ibuprofen Farmalider 20 mg - ml, 40 mg - ml oraalisuspensio SPC 2024-02-23
|
|
|
European Medicines Agency's website: Ibuprofen Gen.Orph - EMA: EPAR PI
Finnish Swedish
|
PL
|
Resepti
|
Ibusal 200 mg, 400 mg tabletti, kalvopäällysteinen SPC 2023-12-12
|
PL
|
Resepti
|
Ibusal 400 mg, 600 mg, 800 mg tabletti, kalvopäällysteinen SPC 2023-12-12
|
PL
|
Itsehoito
|
Ibutabs 400 mg tabletti, kalvopäällysteinen SPC 2023-12-12
|
PL
|
Resepti/itsehoito
|
Ibuver 400 mg tabletti, kalvopäällysteinen SPC 2024-01-17
|
PL
|
Resepti/itsehoito
|
Ibuxin 20 mg - ml, 40 mg - ml siirappi SPC 2024-06-03
|
PL
|
Itsehoito
|
Ibuxin 400 mg jauhe SPC 2024-03-11
|
PL
|
Itsehoito
|
Ibuxin 400 mg tabletti, kalvopäällysteinen SPC 2024-02-02 OTC
|
PL
|
Resepti
|
Ibuxin 400 mg, 600 mg, 800 mg tabletti, kalvopäällysteinen SPC 2024-02-02
|
|
| |